Immunotherapy for ovarian cancer: what are the targets of the future?

被引：12
作者：
Adams, Sarah F. [1 ]
Benencia, Fabian [2 ]
机构：
[1] Univ New Mexico, Ctr Canc, Gynecol Oncol, Albuquerque, NM 87131 USA
[2] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Acad Res Ctr 202C, Athens, OH 45701 USA
来源：
FUTURE ONCOLOGY | 2015年 / 11卷 / 09期
关键词：
chemotherapy; immunotherapy; ovarian cancer; tumor microenvironment; LIPOSOMAL DOXORUBICIN; T-CELLS;
D O I：
10.2217/fon.15.44
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1293 / 1296
页数：4
相关论文
共 20 条
  • [1] Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
    Alagkiozidis, Ioannis
    Facciabene, Andrea
    Carpenito, Carmine
    Benencia, Fabian
    Jonak, Zdenka
    Adams, Sarah
    Carroll, Richard G.
    Gimotty, Phyllis A.
    Hammond, Rachel
    Danet-Desnoyers, Gwen-aeel
    June, Carl H.
    Powell, Daniel J., Jr.
    Coukos, George
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [2] Immunologic consequences of chemotherapy for ovarian cancer: Impaired responses to the influenza vaccine
    Chu, Christina S.
    Boyer, Jean D.
    Jawad, Abbas
    Mcdonald, Kenyetta
    Rogers, Wade T.
    Prak, Eline T. Luning
    Sullivan, Kathleen E.
    [J]. VACCINE, 2013, 31 (46) : 5435 - 5442
  • [3] Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A
    Conejo-Garcia, JR
    Benencia, F
    Coureges, MC
    Kang, E
    Mohamed-Hadley, A
    Buckanovich, RJ
    Holtz, DO
    Jenkins, A
    Na, HN
    Zhang, L
    Wagner, DS
    Katsaros, D
    Caroll, R
    Coukos, G
    [J]. NATURE MEDICINE, 2004, 10 (09) : 950 - 958
  • [4] Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment A dangerous liaison
    Conrad, Curdin
    Gilliet, Michel
    [J]. ONCOIMMUNOLOGY, 2013, 2 (05)
  • [5] Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
    Duraiswamy, Jaikumar
    Kaluza, Karen M.
    Freeman, Gordon J.
    Coukos, George
    [J]. CANCER RESEARCH, 2013, 73 (12) : 3591 - 3603
  • [6] Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation
    Gujar, Shashi
    Dielschneider, Rebecca
    Clements, Derek
    Helson, Erin
    Shmulevitz, Maya
    Marcato, Paola
    Pan, Da
    Pan, Lu-zhe
    Ahn, Dae-Gyun
    Alawadhi, Abdulaziz
    Lee, Patrick W. K.
    [J]. MOLECULAR THERAPY, 2013, 21 (02) : 338 - 347
  • [7] IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer
    Hart, Kevin M.
    Byrne, Katelyn T.
    Molloy, Michael J.
    Usherwood, Edward M.
    Berwin, Brent
    [J]. FRONTIERS IN IMMUNOLOGY, 2011, 2
  • [8] Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity
    Huarte, Eduardo
    Cubillos-Ruiz, Juan R.
    Nesbeth, Yolanda C.
    Scarlett, Uciane K.
    Martinez, Diana G.
    Buckanovich, Ronald J.
    Benencia, Fabian
    Stan, Radu V.
    Keler, Tibor
    Sarobe, Pablo
    Sentman, Charles L.
    Conejo-Garcia, Jose R.
    [J]. CANCER RESEARCH, 2008, 68 (18) : 7684 - 7691
  • [9] T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
    Kalos, Michael
    Levine, Bruce L.
    Porter, David L.
    Katz, Sharyn
    Grupp, Stephan A.
    Bagg, Adam
    June, Carl H.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (95)
  • [10] A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
    Kandalaft, Lana E.
    Chiang, Cheryl L.
    Tanyi, Janos
    Motz, Greg
    Balint, Klara
    Mick, Rosemarie
    Coukos, George
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
12